Table 1.
Flavivirus epidemiology, infection, and complications.
Virus | At Risk Individuals | Annually Reported New Infection Cases | Symptoms | Neurologic Disease | Mortality Rate |
---|---|---|---|---|---|
Japanese Encephalitis Virus (JEV) | Children-Young Adult (0-15 years old) | 35,000-50,000 new cases (in JEV-endemic countries) | Pyrexia, cephalalgia, vomiting neurologic dysfunction, muscle weakness, seizures, loss of motor function | Parkinsonism Flaccid paralysis Coma Acute Encephalitis | ~25-30% |
Dengue (DENV) | No age distinction | one million cases (globally) | Pyrexia, myalgia, vomiting, cephalalgia, abdominal pain, bleeding, low blood pressure, tachycardia, seizures | Encephalitis | ~1-5% |
West Nile Virus (WNV) | Adults and immunocompromised persons(≥ 50 years old at greater risk of developing more severe disease and complications) | Ranging from 20-5674 cases annually between 1999-2012 in the U.S; reports of WNV infection and mortality rates reported in Canada and Mexico | Fever, cephalalgia, nausea, vomiting, myalgia, muscle weakness, lower back pain, loss of motor function | Encephalitis, Meningitis | ~3-15% |
*Data collected from the Centers for Disease Control (www.cdc.gov) and review by Malavige et al, Post-Graduate Medical Journal 80(948):588-601, http://www.cdc.gov/westnile/resources/pdfs/cummulative/99_2012_CasesAndDeathsClinicalPresentationHumanCases.pdf, and http://www.cdc.gov/westnile/resources/pdfs/cummulative/99_2012_cummulativeHumanCases.pdf